Literature DB >> 20118393

Clinical pearls in infectious diseases.

Robert Orenstein1, Scott C Litin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118393      PMCID: PMC2813826          DOI: 10.4065/mcp.2009.0465

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Yuejin Li; Michael J Pultz; Michelle M Riggs; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

3.  The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis.

Authors:  L Petricevic; A Witt
Journal:  BJOG       Date:  2008-10       Impact factor: 6.531

Review 4.  Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data.

Authors:  Jim Young; An De Sutter; Dan Merenstein; Gerrit A van Essen; Laurent Kaiser; Helena Varonen; Ian Williamson; Heiner C Bucher
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

5.  National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

Authors:  William R Jarvis; JoAnn Schlosser; Ashley A Jarvis; Raymond Y Chinn
Journal:  Am J Infect Control       Date:  2009-03-10       Impact factor: 2.918

6.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

Authors:  Fred A Zar; Srinivasa R Bakkanagari; K M L S T Moorthi; Melinda B Davis
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

7.  Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Tina L Fiedler; Kathleen Ringwood; David N Fredricks
Journal:  Ann Intern Med       Date:  2008-07-01       Impact factor: 25.391

8.  Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis.

Authors:  Jean-Pierre Menard; Florence Fenollar; Mireille Henry; Florence Bretelle; Didier Raoult
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

9.  Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.

Authors:  Adriana S Lopez; Andrea Burnett-Hartman; Ram Nambiar; Linda Ritz; Patricia Owens; Vladimir N Loparev; Dalya Guris; D Scott Schmid
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  Varicella-zoster virus in the saliva of patients with herpes zoster.

Authors:  Satish K Mehta; Stephen K Tyring; Donald H Gilden; Randall J Cohrs; Melanie J Leal; Victoria A Castro; Alan H Feiveson; C Mark Ott; Duane L Pierson
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.